Cangrelor use prior to left ventricular assist device surgery: a case series Jeffrey B. WashamBabatunde YerokunAdam D. DeVore BriefCommunication 02 June 2018 Pages: 131 - 133
Non-vitamin K antagonist oral anticoagulants in cardioversion of atrial fibrillation: a network meta-analysis Babikir KheiriTarek HaykalDeepak L. Bhatt Letter to the Editor 15 June 2018 Pages: 134 - 138
Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation Andrea P. RossiRoberto FacchinettiMauro Zamboni OriginalPaper 14 May 2018 Pages: 139 - 144
Direct oral anticoagulants for the treatment of venous thromboembolism in patients with active malignancy: a systematic review and meta-analysis Majed S. Al YamiHisham A. BadreldinAbdulmajeed M. Alshehri OriginalPaper 12 June 2018 Pages: 145 - 153
Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner Kristina SundquistAbrar AhmadAshfaque A. Memon OriginalPaper Open access 18 April 2018 Pages: 154 - 165
Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome Amihai RottenstreichAriela AradYosef Kalish OriginalPaper 30 April 2018 Pages: 166 - 173
Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy Giovanni Luca TisciaAngelo OstuniElvira Grandone OriginalPaper 08 May 2018 Pages: 174 - 179
Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices Jessica RimsansAmy LevesqueJean M. Connors OriginalPaper 21 May 2018 Pages: 180 - 185
A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic Jamal H. MaharIhab HaddadinGustavo A. Heresi OriginalPaper 31 May 2018 Pages: 186 - 192
Impaired fibrinolysis in degenerative mitral and aortic valve stenosis Piotr MazurJacek MyćAnetta Undas OriginalPaper Open access 31 May 2018 Pages: 193 - 202
The utility of total lipid core burden index/maximal lipid core burden index ratio within the culprit plaque to predict filter-no reflow: insight from near-infrared spectroscopy with intravascular ultrasound Takao SatoYoshifusa AizawaMasaaki Okabe OriginalPaper 18 June 2018 Pages: 203 - 210
Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen Liqing ZhuMisheng ZhaoShenmeng Gao OriginalPaper 10 May 2018 Pages: 211 - 218
Experimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor Shogo KasudaYoshihiko SakuraiKatsuhiko Hatake OriginalPaper 02 June 2018 Pages: 219 - 226
Anticoagulation reversal in vitamin K antagonist–associated intracerebral hemorrhage: a systematic review Darae KoZayd RazoukiElaine M. Hylek OriginalPaper 23 April 2018 Pages: 227 - 237
Do hospital doctors test for thrombophilia in patients with venous thromboembolism? Daryoush SamimPedro Marques-VidalMarie Méan OriginalPaper 19 June 2018 Pages: 238 - 243
Protein S deficiency in patients from the French Basque Country with various thrombotic conditions: a rarer inherited trait in autochthonous individuals? Frédéric Bauduer Letter to the Editor 25 May 2018 Pages: 244 - 245
Safety analysis of apixaban versus warfarin in patients with advanced kidney disease Michael BowieViolet ValenciaMinh-Ha Tran OriginalPaper 30 May 2018 Pages: 246 - 252
Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study Dinah KonnerthFlorian SchwarzThomas M. Berghaus OriginalPaper 19 April 2018 Pages: 253 - 259
Anticoagulant-related nephropathy: a pathological note Vincenzo L’ImperioAlessia GuarnieriFabio Pagni Letter to the Editor 20 April 2018 Pages: 260 - 263
The influence of fibrate initiation on INR and warfarin dose in patients receiving chronic warfarin therapy John F. PolnakThomas DelateNathan P. Clark OriginalPaper 21 April 2018 Pages: 264 - 270
Successful treatment with idarucizumab for diffuse alveolar hemorrhage induced by dabigatran etexilate: a case report Akihiro ShiroshitaKei NakashimaMasahiro Aoshima BriefCommunication 08 May 2018 Pages: 271 - 273
